ACCESSWIRE Press Releases

Faron’s Bexmarilimab Data Accepted for Poster Presentation at the BSH Annual Scientific Meeting 2026

TURKU, FI / ACCESS Newswire / February 23, 2026 / Faron Pharmaceuticals Ltd. (HEL:FARON)(LSE:FARN), a clinical-stage biopharmaceutical company focused on tackling cancers through novel immunotherapies, today announces that data from its Phase I/II BEXM…

ACCESSWIRE Press Releases

InterContinental Hotels Group PLC Announces Transaction in Own Shares – February 23

LONDON, UK / ACCESS Newswire / February 23, 2026 / The Company announces that on 20 February 2026 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International (“GSI”) on the London Stock …

ACCESSWIRE Press Releases

Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VI…